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Résumé en
anglais
Background - Extracorporeal photopheresis (ECP) has shown encouraging results in
the prevention of allograft rejection in heart transplantation. However, the role of
ECP in kidney transplant (KT) rejection needs to be determined. Methods - This
multicentre retrospective study included 33 KT recipients who were treated with
ECP for allograft rejection (23 acute antibody-mediated rejections (AMRs), 2 chronic
AMRs and 8 acute cellular rejections (ACRs)). The ECP indications were KT
rejection in patients who were resistant to standard therapies (n = 18) or in patients
for whom standard therapies were contraindicated because of concomitant
infections or cancers (n = 15). Results - At 12 months (M12) post-ECP, 11 patients
(33%) had a stabilization of kidney function with a graft survival rate of 61%. The
Banff AMR score (g + ptc + v) was a risk factor for graft loss at M12 (HR 1.44
[1.01-2.05], p < 0.05). The factorial mixed data analysis identified 2 clusters.
Patients with a functional graft at M12 tended to have cellular and/or chronic
rejections. Patients with graft loss at M12 tended to have acute rejections and/or
AMR; higher serum creatinine levels; DSA levels and histologic scores of AMR; and
a longer delay between the rejection and ECP start than those of patients with
functional grafts. Conclusions - ECP may be helpful to control ACR or moderate
AMR in KT recipients presenting concomitant opportunistic infections or
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